An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Can You (Or Should You) Bring a Baby to a Concert?

Use of a Tablet-Based Mobile Classifier to Diagnose Vestibular Disorders

Vestibular Exercises May Improve Outcomes in Those with Intracerebral Hemorrhage

Recent Posts

Can You (Or Should You) Bring a Baby to a Concert?

Have you ever seen a baby or a young child at a very noisy event? Chances are you have. And often, these infants and young…

Read More

SPAN Members Connect on Student Loan Advocacy and State Legislative Updates

The American Academy of Audiology’s State Policy Advocate Network (SPAN) held its third quarterly meeting on July 22, bringing together Academy members from across the…

Read More

Illinois Governor Signs Hearing Care Plan Transparency

Illinois Governor JB Pritzker signed into law Senate Bill 2838 (SB 2838), a measure designed to increase transparency, strengthen consumer protections, and improve fairness in…

Read More